Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Cardinal Health    CAH

CARDINAL HEALTH

(CAH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period June 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 121 546 129 976 136 809 144 907 150 519 156 815
EBITDA 3 534 2 959 2 910 2 774 2 762 2 826
Operating profit (EBIT) 2 895 2 769 2 585 2 346 2 316 2 377
Pre-Tax Profit (EBT) 2 276 - -228 1 572 1 621 1 385
Net income 1 427 1 288 256 1 326 1 144 1 082
P/E ratio 18,1x 19,3x 60,3x 9,90x 11,6x 11,7x
EPS ( $ ) 4,32 4,03 0,81 4,55 3,89 3,84
Dividend per Share ( $ ) 1,61 1,81 1,86 1,95 2,01 2,15
Yield 2,06% 2,32% 3,82% 4,33% 4,46% 4,77%
Reference price ( $ ) 78,010 77,920 48,830 44,990 44,990 44,990
Announcement Date 08/02/2016
11:00am
08/02/2017
11:00am
08/06/2018
10:55am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period June 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 3 183 3 516 7 250 5 987 5 059 4 534
Finance - - - - - -
Operating income (EBITDA) 3 534 2 959 2 910 2 774 2 762 2 826
Leverage
(Debt/EBITDA)
0,90x 1,19x 2,49x 2,16x 1,83x 1,60x
Capital Expenditure 465 387 384 362 414 421
Book Value Per Share (BVPS) ( $ ) 20,1 21,5 19,5 21,4 22,3 23,0
Cash Flow per Share ( $ ) 9,00 3,70 8,79 7,71 7,74 8,70
Announcement Date 08/02/2016
11:00am
08/02/2017
11:00am
08/06/2018
10:55am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 13 410 M $ -
Entreprise Value (EV) 19 397 M $ 18 469 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 9,90x 11,6x
Capitalization / Revenue 0,09x 0,09x
EV / Revenue 0,13x 0,13x
EV / EBITDA 6,99x 7,02x
Yield (DPS / Price) 4,33% 4,46%
Price to book (Price / BVPS) 2,10x 2,01x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 1,62% 1,54%
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) 0,92% 0,76%
ROA (Net Profit / Asset) 3,83% 3,75%
ROE (Net Profit / Equities) 24,6% 23,5%
Rate of Dividend 42,9% 51,5%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   0,25% 0,27%
Cash Flow / Sales 1,59% 1,53%
Capital Intensity (Assets / Sales) 0,24x 0,20x
Financial Leverage (Net Debt / EBITDA) 2,16x 1,83x
EPS & Dividend